Few clinical trials of turmeric, curcumin or others of its bioactive components have been
conducted. In a study with healthy subjects, the intake of 6g/day turmeric increased
postprandial serum insulin levels, while reducing plasma glucose levels [41]. Adults with type 2 DM treated for eight-weeks with NCB-02, a standardized preparation of
curcuminoids. Do you have experience with this?